Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15.

Ochoa, Maria Carmen; Minute, Luna; López, Ascensión; Pérez-Ruiz, Elisabeth; Gomar, Celia; Vasquez, Marcos; Inoges, Susana; Etxeberria, Iñaki; Rodriguez, Inmaculada; Garasa, Saray; Mayer, Jan-Peter Andreas; Wirtz, Peter; Melero, Ignacio; Berraondo, Pedro.

Ochoa MC; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.
Minute L; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.
López A; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain.
Pérez-Ruiz E; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.
Gomar C; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.
Vasquez M; Servicio de Inmunología e Inmunoterapia, Clínica Universidad de Navarra, Pamplona, Spain.
Inoges S; Hematología y Área de Terapia Celular, Clínica Universidad de Navarra, Pamplona, Spain.
Etxeberria I; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.
Rodriguez I; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.
Garasa S; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.
Mayer JA; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.
Wirtz P; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.
Melero I; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.
Berraondo P; Servicio de Inmunología e Inmunoterapia, Clínica Universidad de Navarra, Pamplona, Spain.